AnaptysBio Inc (ANAB)
21.27
-1.44
(-6.34%)
USD |
NASDAQ |
Apr 15, 16:00
21.30
+0.03
(+0.14%)
After-Hours: 20:00
AnaptysBio Total Assets (Quarterly): 452.39M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 452.39M |
| September 30, 2023 | 487.33M |
| June 30, 2023 | 517.10M |
| March 31, 2023 | 551.79M |
| December 31, 2022 | 610.38M |
| September 30, 2022 | 618.50M |
| June 30, 2022 | 603.85M |
| March 31, 2022 | 625.17M |
| December 31, 2021 | 643.07M |
| September 30, 2021 | 424.34M |
| June 30, 2021 | 426.57M |
| March 31, 2021 | 396.42M |
| December 31, 2020 | 416.55M |
| September 30, 2020 | 384.75M |
| June 30, 2020 | 401.75M |
| March 31, 2020 | 424.23M |
| December 31, 2019 | 435.20M |
| September 30, 2019 | 451.50M |
| Date | Value |
|---|---|
| June 30, 2019 | 480.15M |
| March 31, 2019 | 494.23M |
| December 31, 2018 | 509.00M |
| September 30, 2018 | 523.12M |
| June 30, 2018 | 306.02M |
| March 31, 2018 | 314.84M |
| December 31, 2017 | 329.36M |
| September 30, 2017 | 121.94M |
| June 30, 2017 | 130.41M |
| March 31, 2017 | 131.11M |
| December 31, 2016 | 62.18M |
| September 30, 2016 | 55.84M |
| June 30, 2016 | 58.50M |
| March 31, 2016 | 54.72M |
| December 31, 2015 | 56.28M |
| September 30, 2015 | 60.88M |
| June 30, 2015 | 22.29M |
| December 31, 2014 | 25.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
384.75M
Minimum
Sep 2020
643.07M
Maximum
Dec 2021
492.16M
Average
452.39M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Fate Therapeutics Inc | 506.22M |
| Ocular Therapeutix Inc | 252.06M |
| Apellis Pharmaceuticals Inc | 788.73M |
| Stoke Therapeutics Inc | 228.34M |
| Vor Biopharma Inc | 198.13M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 364.29M |
| Shareholders Equity (Quarterly) | 88.10M |
| Current Ratio | 10.87 |